Search Results 31-40 of 10826 for egfr

  1. Clinical trials - Oncology (Medical)

    Patients with known EGFR (Epidermal growth factor receptor) tyrosine kinase (TK) activating mutations and anaplastic lymphoma kinase (ALK) rearrangements ...

  2. Researchers Use Genomic Sequencing to Help Identify New Therapies for Bile Duct Cancer - Mayo Clinic News Network

    Study targets EGFR and FGFR cellular pathways to treat rare disease. SCOTTSDALE, Ariz. — Feb. 13, 2014 — Physicians at Mayo Clinic's Center for ...

  3. An Open-label Study Using ASP-1929 Photoimmunotherapy In Combination With Anti-PD1 Therapy In EGFR Expressing Advanced Solid Tumors - Mayo Clinic

    An Open-label Study Using ASP-1929 Photoimmunotherapy In Combination With Anti-PD1 Therapy In EGFR Expressing Advanced Solid Tumors · Share · Facebook · Twitter.

  4. Study Of ORIC-114 In Patients With Advanced Solid Tumors Harboring An EGFR Or HER2 Alteration - Mayo Clinic

    Study Of ORIC-114 In Patients With Advanced Solid Tumors Harboring An EGFR Or HER2 Alteration ... EGFR or HER2 alteration. Participation eligibility.

  5. Top 5 reasons to refer a patient early for kidney transplant - Mayo Clinic

    A transplant nephrologist at Mayo Clinic outlines suggested criteria for referring a patient for a potential kidney transplant.

  6. Mayo Clinic opens new doors in cancer treatment innovation

    These include human epidermal growth factor receptor 2 (HER2), epidermal growth factor receptor (EGFR), and mesenchymal-epithelial transition factor (MET).

  7. Transthyretin amyloid cardiomyopathy (ATTR-CM) - Stages - Mayo Clinic

    The National Amyloidosis Centre staging system uses NT-proBNP and a measure of kidney function called estimated glomerular filtration rate (eGFR). It can be ...

  8. Hemodialysis - Mayo Clinic

    A lower eGFR means your kidneys are filtering less well. The decision to start hemodialysis is not based on eGFR alone. It also depends on your symptoms, ...

  9. MRI: Is gadolinium safe for people with kidney problems? - Mayo Clinic

    Older versions of contrast agents that contain gadolinium increase the risk of a rare but serious disease called nephrogenic systemic fibrosis. This disease ...

  10. A Study To Explore The Renal Safety Of Visipaque Injection 320 MgI/mL In Patients With Chronic Kidney Disease - Mayo Clinic

    Has a documented diagnosis of stage III or IV (defined as 30≤ estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m² and 15 ≤eGFR <30 mL/min/1.73 ...